PeptiMed peptimed.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

PeptiMed has invented a proprietary siRNA therapeutic drug that targets the EVI1 gene, called siEVI1, for treatment of advanced breast, prostate, lung, colon, ovarian, and skin cancer. The drug may be used initially as a second-line therapy, and advanced to first-line therapy once proven effective as a stand-alone treatment.

PeptiMed has invented a proprietary siRNA therapeutic drug that targets the EVI1 gene, called siEVI1, for treatment of advanced breast, prostate, lung, colon, ovarian, and skin cancer. The drug may be used initially as a second-line therapy, and adva...Show all

Company (Alive / Active)

Phone: 608-335-462

Fax:

921 Walsh Road
Suite 208
Jefferson, 53549
Wisconsin, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PeptiMed $0.2M Jun 23, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PeptiMed Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
HealthCare VenturesVenture CapitalCambridge, Massachusetts, United StatesOther Investors
Undisclosed InvestorsOtherUnattributed
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Reagents and methods for treating cancer May 23, 2011 Mar 01, 2016 Patent
Compositions of a peptide targeting system for treating cancer Nov 01, 2011 Mar 25, 2014 Patent
Reagents and methods for treating cancer Jan 22, 2016 Application
Anti-tumor compositions and methods Jun 15, 2015 Application